Pages that link to "Q45833318"
Jump to navigation
Jump to search
The following pages link to The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer (Q45833318):
Displaying 50 items.
- Management of HBV Infection in Liver Transplantation Patients (Q24529103) (← links)
- Distinct modes of regulation of transcription of hepatitis B virus by the nuclear receptors HNF4alpha and COUP-TF1 (Q24541373) (← links)
- Prevention of Hepatitis B reactivation in the setting of immunosuppression (Q26747023) (← links)
- Prophylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New? (Q26781880) (← links)
- Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective (Q28388806) (← links)
- High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients (Q33627472) (← links)
- Critical roles of nuclear receptor response elements in replication of hepatitis B virus (Q33849658) (← links)
- The difficulties of managing severe hepatitis B virus reactivation. (Q34157424) (← links)
- The hepatologist in the haematologists' camp (Q34266309) (← links)
- Retinazone inhibits certain blood-borne human viruses including Ebola virus Zaire. (Q34342378) (← links)
- Hepatitis B: progress in the last 15 years (Q34936238) (← links)
- Reverse seroconversion of hepatitis B virus after hematopoietic stem cell transplantation. (Q35047635) (← links)
- Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with hemato-oncological neoplasias treated with chemotherapy (Q35152610) (← links)
- Treatment of hepatitis B in decompensated liver cirrhosis (Q35207784) (← links)
- The role of hepatitis B virus in the development of primary hepatocellular carcinoma: Part I. (Q35238054) (← links)
- Natural history of hepatitis b and outcomes after liver transplantation (Q35543568) (← links)
- Immunosuppression in hepatitis B virus and hepatitis C virus transplants: special considerations (Q35543610) (← links)
- Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure (Q35567748) (← links)
- Direct modulation of simian virus 40 late gene expression by thyroid hormone and its receptor (Q35875001) (← links)
- Treatment of follicular non-Hodgkin's lymphoma (Q35989683) (← links)
- Is hepatitis B immunoglobulin prophylaxis needed for liver transplantation in the era of new antivirals? (Q36167229) (← links)
- Infectious risk in pediatric organ transplant recipients: is it increased with the new immunosuppressive agents? (Q36209765) (← links)
- Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily (Q36548875) (← links)
- Long-Term Outcomes of Simultaneous Liver-Kidney Transplant Patients with Hepatitis B Compared to with Liver Transplant Alone (Q36551248) (← links)
- Prevention of hepatitis B virus recurrence after liver transplantation (Q36652077) (← links)
- Transcriptional Control of Hepadnavirus Gene Expression (Q36682193) (← links)
- Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus (Q36698734) (← links)
- The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function (Q36782875) (← links)
- Transcription of the S gene in transgenic mice is associated with hypomethylation at specific sites and with DNase I sensitivity (Q36801548) (← links)
- Prophylaxis of hepatitis B infection in solid organ transplant recipients (Q36886518) (← links)
- Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management. (Q36951280) (← links)
- Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management (Q37764963) (← links)
- Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression (Q37833669) (← links)
- Hepatitis B recurrence after liver transplantation: a single center experiences and review the literature (Q38088688) (← links)
- Functional organization of the hepatitis B virus enhancer (Q38340159) (← links)
- Function of directly repeated half-sites as response elements for steroid hormone receptors (Q38357615) (← links)
- Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy (Q38408897) (← links)
- HBV reactivation in a HBsAg-negative patient with multiple myeloma treated with prednisolone maintenance therapy after autologous HSCT. (Q38427424) (← links)
- Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5). (Q38947451) (← links)
- The metabolic regulator PGC-1α links anti-cancer cytotoxic chemotherapy to reactivation of hepatitis B virus. (Q39227989) (← links)
- Strategies for the prevention of recurrent hepatitis B virus infection after liver transplantation (Q39372160) (← links)
- Nuclear receptor mRNA expression by HBV in human hepatoblastoma cell lines (Q39477113) (← links)
- The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro (Q39589532) (← links)
- Repression of hepatitis B viral gene expression by transcription factor nuclear factor-kappaB. (Q39895866) (← links)
- A new enhancer element, ENII, identified in the X gene of hepatitis B virus. (Q40110349) (← links)
- Corticosteroids in kidney transplant recipients. Safety issues and timing of discontinuation (Q40380386) (← links)
- Long-term effect of interferon therapy in chronic hepatitis B. (Q40390263) (← links)
- Defining a minimal estrogen receptor DNA binding domain (Q40405712) (← links)
- Fibrosing cholestatic hepatitis and HBV after bone marrow transplantation (Q40466510) (← links)
- Liver transplantation in virus-induced chronic liver disease (Q41157505) (← links)